News

The Manila Times1d
Biocon Biologics Receives Health Canada Approval for Yesafili™ (aflibercept); First Global Launch Scheduled for July 2025
TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a ...
Biocon Biologics Receives Health Canada Approval For Yesafilitm (Aflibercept) First Global Launch Scheduled For July 2025
TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL) , a fully integrated ...
Biocon Biologics Ltd: Biocon Biologics Receives Health Canada Approval for Yesafili (aflibercept); First Global Launch Scheduled for July 2025
TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BS ...
pharmaphorum1d
A history of Bayer - pharmaphorum
Bayer has been around for more than 150 years, and has continued to evolve throughout its long history. Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what ...
pharmaphorum2d
After earlier rejection, high-dose Eylea clears FDA
Regeneron reported Eylea sales of $4.7 billion in the first six months of the year - a decline of 4%, with $2.9 billion from that total coming from the US market.
Morningstar3d
REGN Stock Price Quote | Morningstar
See the latest Regeneron Pharmaceuticals Inc stock price (REGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.